RX Drugnews homepage

  • U-Kera Cream (Taropharma)


    U-Kera is a keratolytic emollient which is a gently, yet potent, tissue softener for nails and/or skin. Each gram of U-Kera contains urea USP (40%), purified water USP, light mineral oil NF, white petrolatum USP, glycolic acid, propylene glycol USP, trolamine NF, glyceryl stearate SE, cetyl alcohol NF, L-arginine USP, and xanthan gum NF.



    Urea gently dissolves the intercellular matrix which results in loosening the horny layer of skin and shedding scaly skin at regular intervals, thereby softening hyperkeratotic areas. Urea also hydrates and gently dissolves the intercellular matrix of the nail plate, which can result in the softening and eventual debridement of the nail plate.

    PHARMACOKINETICS:    The mechanism of action of topically applied urea is not yet known.


    For debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma, corns and calluses, as well as damaged, ingrown and devitalized nails.


    Known hypersensitivity to any of the listed ingredients.


    For external use only. Avoid contact with eyes, lips or mucous membranes.


    This medication is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use.

    PREGNANCY:    Pregnancy Category C. Animal reproduction studies have not been conducted with U-Kera™. It also is not known whether U-Kera™ can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. U-Kera™ should be given to a pregnant woman only if clearly needed.

    NURSING MOTHERS:    It is not known whether or not this drug is secreted in human milk. Because many drugs are secreted in human milk, caution should be exercised when U-Kera™ is administered to a nursing woman.



    Transient stinging, burning, itching and irritation may occur and normally disappear on discontinuing the medication.


    Apply U-Kera to affected areas. Protect surrounding tissue. Smooth over affected tissue, nail or skin area(s) until cream is absorbed. If desired, cover with adhesive bandage or gauze, secured with adhesive tape. When applying to diseased or damaged nail surfaces, use an ample amount. Cover as above. An option is then to remove a "finger" from a plastic or vinyl glove and slip over the bandage-covered site. Secure glove finger with additional adhesive tape. Keep dry and occlusive for 3-7 days.


    U-Kera Urea Cream, 40% is supplied in tubes containing 28.35 g (1 oz) NDC 51672-1329-2, 85.05 g (3 oz) NDC 51672-1329-8, and 198.45 g (7 oz) NDC 51672-1329-7.

    Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature]. Protect from freezing.

    Mfd. by: Taro Pharmaceuticals Inc.

    Brampton, Ontario, Canada L6T 1C1

    Dist. By: Taropharma

    A division of Taro Pharmaceuticals U.S.A., Inc.

    Hawthorne, NY 10532

    U-Kera™ and Taropharma™ are trademarks of Taro Pharmaceuticals U.S.A., Inc. and/or its affiliates.

    U-Kera™ is sold by Taro Pharmaceuticals U.S.A., Inc. under license from Medicis Pharmaceutical Corporation.

    Revised: July 2005

    How to properly use
    Urea Cream, 40%

    Rx only

    Gentle, yet potent, tissue softener for skin or nails.

    Easy steps to gently thin and soften thick, rough or dry skin seen, to various degrees, in psoriasis, xerosis, ichthyosis, keratosis, keratoderma, dermatitis, pruritus, eczema and calluses, as well as damaged, diseased or devitalized and ingrown nails.

    For skin tissue:

    1. Apply U-Kera to affected skin tissue twice per day, or as directed by a physician.
    2. Rub in until completely absorbed.

    For nail tissue:

    1. Apply U-Kera to affected nail tissue twice per day, or as directed by a physician.
    2. Let dry uncovered or apply and cover with adhesive bandage or gauze secured with adhesive tape.

Subscribe to the "News" RSS Feed RSS



About Us   |  Privacy Policy   |  Terms of Use   |  Contact Us  

© 2012 RxDrug News 1999-2016. All rights reserved